Gynae - Uterine, Cervical, Vulvovaginal Disorders Flashcards

1
Q

Chronic Pelvic Pain

Definition
Clinical Features
Differential Diagnoses
Investigations

A

1.) Definition - intermittent or constant pain >6 months in the lower abdomen or pelvis not exclusively due to menstruation, intercourse or pregnancy

  1. ) Clinical Features
    - persistent lower abdominal pain
    - painful: periods, intercourse, defecation, urination
    - heavy periods, IMB, PCB, rectal bleeding, epistaxis
    - pelvic examination: NAD, thickened uterosacral ligaments, fixed retroverted uterus, uterine/ovarian enlargement, uterine or forniceal tenderness
  2. ) Differential Diagnoses
    - endometriosis and adenomyosis, ovarian cysts
    - PID, pelvic adhesions, IBS/IBD, interstitial cystitis
    - MSK, nerve entrapment, social/psychological factors
  3. ) Investigations
    - abdominal and pelvic examination, speculum
    - STI screening
    - imaging (TVUS, MRI laparoscopy): identify and assess adnexal masses, adenomyosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Differentials for Chronic Pelvic Pain

Adhesions
IBS and Interstitial Cystitis
MSK Pain and Nerve Entrapment

A
  1. ) Adhesions - post-surgical complication
    - residual ovarian syndrome: preserved ovaries after a hysterectomy causing chronic pelvic pain
    - ovarian remnant syndrome: ovarian tissue left behind after an oophorectomy causing pelvic pain
    - treatment is GnRH analogues or surgical removal
  2. ) IBS and Interstitial Cystitis
    - IBS will have other bowel symptoms
    - IC has other urinary sx: frequency, urgency, nocturia, pain worse with a full bladder
  3. ) MSK Pain and Nerve Entrapment
    - source of MSK: pelvic joints, muscle damage to the pelvic floor or abdominal wall, pelvic organ prolapse
    - NE: highly localised, sharp, stabbing or aching pain
    - Tx: analgesia, physio, nerve modulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Endometriosis

Pathophysiology
Risk Factors
Clinical Features
Differential Diagnoses

A
  1. ) Pathophysiology - endometrial tissue located at abnormal sites due to “retrograde menstruation”
    - locations: ovaries, pouch of Douglas, uterosacral ligaments, peritoneum, bladder, umbilicus and lungs
    - oestrogen dependent: sx are cyclical with periods, sx are therefore reduced in pregnancy and menopause
    - bleeding from ectopic tissue during menstruation, repeated inflammation can occur leading to adhesions
  2. ) Risk Factors
    - early menarche, uterine/fallopian defects, FH
    - short menstrual cycles, HMB, long bleeding duration
  3. ) Clinical Features
    - cyclical pelvic pain occurring during menstruation
    - constant pain in cases where adhesions have formed
    - other sx: dysmenorrhoea, dyspareunia, dysuria, dyschezia (difficult, painful defecating), and subfertility
    - focal sx of bleeding at ectopic sites during periods: e.g. bloating (abdo), haemothorax (lungs)
    - bimanual: fixed, retroverted uterus, uterosacral ligament nodules, general tenderness
  4. ) Differential Diagnoses
    - PID, ectopic pregnancy, fibroids, IBS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management of Endometriosis

Investigations
Medical Management
Surgical Management

A
  1. ) Investigations
    - laparoscopy (gold): chocolate cysts, adhesions, peritoneal deposits, effective at differentiating from PID
    - pelvic USS: helps determine severity, done before surgery, can see “kissing ovaries”
  2. ) Medical Management
    - NSAIDs and analgesia is the first-line management
    - suppressing ovulation: ↓oestrogen can cause atrophy of the lesion, using COCP, POP, or Mirena-IUS
    - danazol: suppresses gonadotropin release
  3. ) Surgical Management - if severely affected QoL
    - excision, fulguration and laser ablation aim to completely remove the ectopic endometrial tissue
    - relapses often occur so may need to be repeated
    - definitive management: TAH + BSO w/ HRT until menopause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adenomyosis

Pathophysiology
Risk Factors
Clinical Features

A
  1. ) Pathophysiology - the presence of functional endometrial tissue within the myometrium of the uterus
    - occurs when endometrial stroma communicates with the underlying myometrium after uterine damage due to pregnancy/childbirth, C-section, surgery (inc TOP)
    - invasion can be focal or diffuse, more common in the posterior wall of uterus, can find blood in myometrium
    - adenomyoma: a collection of endometrial glands that form grossly visible nodules in the myometrium
    - oestrogen dependent: sx are therefore reduced in pregnancy and menopause
  2. ) Risk Factors
    - multiparity: often occurs towards menopause (40-60s)
    - any uterine surgery, C-section, FH
  3. ) Clinical Features
    - HMB, irregular bleeding, deep dyspareunia
    - progressive dysmenorrhoea: cyclical –> daily
    - frequently occurs with fibroids
    - examination: symmetrically enlarged boggy (tender) uterus may be palpable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Management of Adenomyosis

Investigations
Hormonal Management
Non-Hormonal Mangement

A
  1. ) Investigations
    - MRI (gold): irregular thickening of the endo–myometrial junctional zone is the hallmark of adenomyosis
    - transvaginal USS: globular uterine configuration, poor definition of the endometrial-myometrial interface, myometrial anterior-posterior asymmetry, myometrial cysts, heterogeneous myometrial echotexture
    - definitive diagnosis: biopsy post-hysterectomy or a hysteroscopic biopsy
  2. ) Hormonal Management - reduce the proliferation of the ectopic endometrial cells, cycle control, ↓bleeding
    - COCP, POP, Mirena-IUS
    - GnRH agonists, aromatase inhibitors
  3. ) Non-Hormonal Mangement
    - pain: analgesia and NSAIDs
    - hysterectomy: only curative therapy
    - uterine artery embolisation: to preserve fertility, reduce blood supply to the adenomyosis –> shrinks
    - other: endometrial ablation/resection, laparoscopic excision and MRI-guided focused ultrasound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fibroids (Leiomyoma)

Pathophysiology
Risk Factors
Clinical Features
Differential Diagnosis

A
  1. ) Pathophysiology - benign smooth muscle tumours arising from the myometrium of the uterus, their growth is thought to be stimulated by oestrogen
    - very rarely becomes malignant (0.1% risk)
    - classified via their position in the uterine wall
    - intramural (most common): confined to myometrium
    - submucosal: develops immediately underneath the endometrium and protrudes into the uterine cavity
    - subserosal: protrudes into and distort the serosal (outer) surface of the uterus, may be pedunculated
  2. ) Risk Factors
    - obesity, early menarche, increasing age
    - FH: affected 1st-degree relative ↑risk by 2.5x
    - ethnicity: black people (3x more likely)
  3. ) Clinical Features
    - majority are asymptomatic and fibroids are often discovered incidentally on pelvic or abdo examination
    - if they are symptomatic, they may have:
    - menorrhagia (HMB), may have abdo distension
    - pressure sx: inc frequency or urinary retention
    - subfertility: obstructive effect of the fibroid
    - acute pelvic pain is rare but may occur in pregnancy due to red degeneration where increased oestrogen levels cause excessive growth of the fibroid
    - if large enough, may undergo torsion
    - abdo/bimanual: a solid mass or enlarged uterus may be palpable, the uterus is usually non-tender
  4. ) Differential Diagnosis
    - endometrial polyp, ovarian tumours, adenomyosis
    - leiomyosarcoma: malignancy of the myometrium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of Fibroids

Investigations
Medical Management
Surgical

A
  1. ) Investigations
    - imaging: pelvic USS, MRI (if a sarcoma is suspected)
    - blood tests are usually reserved where the diagnosis is unclear, or as a pre-op work-up if surgery is needed
  2. ) Medical Management - if symptomatic (HMB), <3cm in size, and not distorting the uterine cavity
    - tranexamic or mefenamic acid: only for bleeding
    - hormonal contraceptives: inc COCP, POP, Mirena-IUS
    - GnRH analogues (Goserelin/Zolidex): suppresses ovulation, useful pre-op to ↓fibroid size and lower complications, used short term (6mths) due to side effects of menopausal sx and reduced bone density
    - SPRM (Ulipristal/Esmya): ↓size of the fibroid and menorrhagia, Ulipristal can cause severe liver injury
  3. ) Surgical - for larger fibroids e.g. >3cm
    - hysteroscopy + transcervical resection of fibroid (TCRF): this is useful for submucosal fibroids
    - myomectomy: for women who want to remain fertile
    - uterine artery embolization (UAE): commonly causes pain and fever post-operatively
    - hysterectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ovarian Torsion

Pathophysiology
Risk Factors
Clinical Features
Management

A
  1. ) Pathophysiology - partial or complete torsion of the ovary on it’s supporting ligaments
    - may in turn compromise the blood supply
    - adnexal torsion: If the fallopian tube is also involved
  2. ) Risk Factors
    - ovarian mass: present in around 90% of cases
    - reproductive age, pregnancy
    - ovarian hyperstimulation syndrome
  3. ) Clinical Features
    - sudden onset of deep-seated colicky abdominal pain
    - associated with vomiting and distress
    - fever in a minority (due to adnexal necrosis)
    - examination: adnexal tenderness
  4. ) Management
    - TVUS: may show whirlpool sign or free fluid
    - laparoscopy: is diagnostic and therapeutic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly